CCAAT/enhancer binding protein δ is a transcriptional repressor of α-synuclein-Reference-Cited by-同舟云学术

CCAAT/enhancer binding protein δ is a transcriptional repressor of α-synuclein

Published:2019-06-17 Issue:2 Volume:27 Page:509-524
ISSN:1350-9047
Container-title:Cell Death & Differentiation
language:en
Short-container-title:Cell Death Differ

Author:

Valente Tony,Dentesano Guido,Ezquerra Mario,Fernandez-Santiago Ruben^ORCID,Martinez-Martin Jonatan,Gallastegui Edurne,Domuro Carla,Compta Yaroslau,Martí Maria J.,Bachs Oriol,Márquez-Kisinousky Leonardo,Straccia Marco,Solà Carme,Saura Josep

Funder

Ministry of Economy and Competitiveness | Instituto de Salud Carlos III

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology

Link

http://www.nature.com/articles/s41418-019-0368-8.pdf

Reference64 articles.

1. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science. 1997;276:2045–7.

2. Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S, et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson’s disease. Nat Genet. 1998;18:106–8.

3. Zarranz JJ, Alegre J, Gomez-Esteban JC, Lezcano E, Ros R, Ampuero I, et al. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol. 2004;55:164–73.

4. Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, et al. alpha-Synuclein locus triplication causes Parkinson’s disease. Science. 2003;302:841.

5. Ibanez P, Bonnet AM, Debarges B, Lohmann E, Tison F, Pollak P, et al. Causal relation between alpha-synuclein gene duplication and familial Parkinson’s disease. Lancet. 2004;364:1169–71.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into dietary phytochemicals targeting Parkinson's disease key genes and pathways: A network pharmacology approach;Computers in Biology and Medicine;2024-04

2. MicroRNA-32-3p facilitates cerebral ischemia/reperfusion injury through inhibiting Cab39/AMPK;International Immunopharmacology;2023-08

3. Competing endogenous RNA (ceRNA) networks in Parkinson's disease: A systematic review;Frontiers in Cellular Neuroscience;2023-01-24

4. Genetic modifiers of synucleinopathies—lessons from experimental models;Oxford Open Neuroscience;2023

5. Intronic enhancers of the human SNCA gene predominantly regulate its expression in brain in vivo;Science Advances;2022-11-25